
CoMind is a London‑based neurotechnology company that develops non‑invasive, light‑based brain monitoring hardware and the AI‑driven CoVision platform. Their system delivers multidimensional, real‑time insights into brain activity across intensive care, surgery, and emergency settings, enabling clinicians to predict complications and tailor precision medicine. By combining neuroscience, machine learning, and wearable hardware, CoMind improves patient safety, clinical outcomes, and healthcare economics. The company’s innovative approach and backing from top investors make it a leading force in redefining brain health.
At CoMind, we are developing a non-invasive neuromonitoring technology that will result in a new era of clinical brain monitoring. As Director of Market Access & Clinical Acceptance, you will own and execute CoMind's strategy for bringing a first-in-class neuromonitoring technology into clinical practice.
CoMind is a London‑based neurotechnology company that develops non‑invasive, light‑based brain monitoring hardware and the AI‑driven CoVision platform. Their system delivers multidimensional, real‑time insights into brain activity across intensive care, surgery, and emergency settings, enabling clinicians to predict complications and tailor precision medicine. By combining neuroscience, machine learning, and wearable hardware, CoMind improves patient safety, clinical outcomes, and healthcare economics. The company’s innovative approach and backing from top investors make it a leading force in redefining brain health.